Drugs, Drugs and More Drugs

Derms on Drugs · Jan 9, 2026 · 53m

Get ready for a no-nonsense tour-de-force of practical application in the latest derm literature. Pipeline drugs, new approvals, brand names, generics—and HS data you’re better off ignoring (we’ll tell you why).

In this episode:

· Leqselvi: the newest JAK for alopecia areata—actually different, or more of the same?

· HS & spondyloarthritis: are you screening… should you be?

· JAKs and the heart: are all cardiovascular risks created equal?

· “2/3 HS remission” headlines: why this data shouldn’t change your practice

· Tirbanibulin + cryo for AKs: combo win or marketing math?

·…